Evofem Biosciences Inc.

NASDAQ: EVFMHealthcare / Biotechnology / USA
4.78-0.1100-2.25%Vol 12 5641Y Perf 117.65%
Aug 20th, 2019 16:00
BID4.78 ASK4.82
Open5.08 Previous Close4.89
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.25 
Analyst Rating
Strong Buy 1.00
Potencial %
114.44 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/50 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/57 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/78 
Income Ranking
 —    -
Market Cap (mil)223 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
51.48 
Earnings Date
6th Aug 2019

Today's Price Range

4.765.08

52wk Range

2.177.24

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-11.65%
1 Month
-2.85%
3 Months
-6.27%
6 Months
37.36%
1 Year
117.65%
3 Years
-8.43%
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
EVFM4.78-0.1100-2.25
AAPL210.610.26000.12
GOOG1 182.69-15.7600-1.32
MSFT137.26-1.1500-0.83
XOM69.03-0.4200-0.60
WFC44.68-0.5700-1.26
JNJ130.60-1.6500-1.25
FB183.81-2.3600-1.27
GE8.38-0.2900-3.34
JPM107.31-1.3800-1.27
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.35-0.350.00
Q01 2019-0.45-0.50-11.11
Q04 2018-0.43-0.58-34.88
Q03 2018-0.37-0.71-91.89
Q02 2018-0.52-1.11-113.46
Q04 2016--0.84-
Q02 2016--0.19-
Q01 2016--0.44-
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.313.13Positive
12/2019 QR-0.2919.44Positive
12/2019 FY-1.348.22Positive
12/2020 FY-1.202.44Positive
Next Report Date-
Estimated EPS Next Report-0.35
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume12 564
Shares Outstanding (in ths.)46 601
Trades Count224
Dollar Volume200 114
Avg. Volume72 729
Avg. Weekly Volume23 391
Avg. Monthly Volume33 323
Avg. Quarterly Volume101 696
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (20.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.20

Evofem Biosciences Inc.

Evofem Biosciences Inc provides woman-controlled protection from sexually transmitted infections. It addresses women's unmet medical needs through the discovery, development and commercialization of healthcare products. Evofem's products that are in development phase include Amphora primarily for the prevention of pregnancy and prevention of urogenital chlamydia and gonorrhea.

CEO: Saundra Pelletier

Teplephone: +1 858 550-1900

Address: 12400 High Bluff Drive, San Diego 92130, CA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

38%63%

Bearish Bullish

50%50%

Bearish Bullish

71%29%

News